Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03040453

Immunological Response After Ablative Therapy in the Liver

Comparison of Immunological Response After Microwave Ablation and Irreversible Electroporation of Hepatocellular Carcinoma

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Local ablative treatment of Hepatocellular Carcinoma is performed primary on patients not eligible for liver transplant or liver resection. At our Hospital two different methods are used: Microwave ablation, where the tumor cells are heated up and killed, and Irreversible electroporation, where the tumor cells are exposed to an electrical field and nano-pores are formed in the cell membranes and the cells go into apoptosis (programed cell death). Previous studies have shown effects on the immune system after ablative therapies. The purpose of this study is to compare the immunological response after the wo different methods of killing the tumor cells.

Conditions

Interventions

TypeNameDescription
DEVICEMicrowave ablation
DEVICEIrreversible electroporation

Timeline

Start date
2017-01-01
Primary completion
2018-06-30
Completion
2018-09-30
First posted
2017-02-02
Last updated
2020-11-30

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03040453. Inclusion in this directory is not an endorsement.